Company: OSRH
Filing Date: 2025-11-25
Form Type: 8-K
Source: 0001213900-25-114496
Chunk: 0

Company: OSR Holdings, Inc.
Filing Date: 2025-11-25
Form: 8-K
Item: Item 7.01
Chunk 0
---
Item 7.01. Regulation FD Disclosure

On November 21, 2025, the Company issued a press release announcing
that its Swiss-based subsidiary, Vaximm AG, entered into a global license term sheet with BCM Europe AG for the VXM01 oral immunotherapy
platform. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.

The information in this Item 7.01 and Exhibit 99.1 is being furnished
and shall not be deemed “filed” for purposes of Section 18 of the Exchange Act.

Item 8.01. Other Events